The available data speaks for itself. Reports indicate that COVID-19 vaccines account for 12% of global pharmacovigilance, and nearly 12,000 studies are currently underway to investigate potential links with various diseases. In France, the National Agency for the Safety of Medicines recorded no fewer than 193,934 reports of adverse events, including 1,635 deaths, in its June 2023 report. These figures, based on a passive pharmacovigilance system, are likely a significant underestimate, according to many observers.
This situation raises fundamental questions about the transparency of health authorities and the risk-benefit ratio of these hastily introduced vaccines. A document published by Pfizer under legal pressure finally provides a more comprehensive overview of the risks to which millions of vaccinated people worldwide are exposed.
,Share your opinion in the comments.
